The nontriptan antimigraine agent SB-220453 has a novel mechanism, no vasoconstrictor activity June 29, 1999
Dual AMPA receptor and voltage-gated sodium channel antagonist under study at Boehringer Ingelheim June 28, 1999
Pharmacia & Upjohn discloses new compounds interacting with the kynurenine metabolic pathway June 28, 1999
Melatonergic agents synthesized at ADIR useful for sleep disorders, anxiety, arrhythmias, etc. June 28, 1999
RSS